BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38695888)

  • 1. External validation of population pharmacokinetic models of tacrolimus in Thai adult liver transplant recipients.
    Komenkul V; Sukarnjanaset W; Komolmit P; Wattanavijitkul T
    Eur J Clin Pharmacol; 2024 Aug; 80(8):1229-1240. PubMed ID: 38695888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients.
    Cai X; Li R; Sheng C; Tao Y; Zhang Q; Zhang X; Li J; Shen C; Qiu X; Wang Z; Jiao Z
    Eur J Pharm Sci; 2020 Mar; 145():105237. PubMed ID: 32001346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients.
    Zhao CY; Jiao Z; Mao JJ; Qiu XY
    Br J Clin Pharmacol; 2016 May; 81(5):891-907. PubMed ID: 26574188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co-administered with tacrolimus.
    Zhang HX; Sheng CC; Liu LS; Luo B; Fu Q; Zhao Q; Li J; Liu YF; Deng RH; Jiao Z; Wang CX
    Br J Clin Pharmacol; 2019 Apr; 85(4):746-761. PubMed ID: 30597603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Performance of Published Tacrolimus Population Pharmacokinetic Models in Thai Kidney Transplant Patients.
    Methaneethorn J; Lohitnavy M; Onlamai K; Leelakanok N
    Eur J Drug Metab Pharmacokinet; 2022 Jan; 47(1):105-116. PubMed ID: 34817826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes.
    Hu C; Yin WJ; Li DY; Ding JJ; Zhou LY; Wang JL; Ma RR; Liu K; Zhou G; Zuo XC
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1437-1447. PubMed ID: 30019212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetic Evaluation with External Validation of Tacrolimus in Chinese Primary Nephrotic Syndrome Patients.
    Yang L; Yang N; Yi B; Pei Q; Huang Z
    Pharm Res; 2022 Aug; 39(8):1907-1920. PubMed ID: 35650450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients.
    Zhu J; Campagne O; Torrice CD; Flynn G; Miller JA; Patel T; Suzuki O; Ptachcinski JR; Armistead PM; Wiltshire T; Mager DE; Weiner DL; Crona DJ
    Clin Transl Sci; 2021 May; 14(3):908-918. PubMed ID: 33502111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients.
    Huang H; Liu Q; Zhang X; Xie H; Liu M; Chaphekar N; Wu X
    Front Pharmacol; 2022; 13():835037. PubMed ID: 35873594
    [No Abstract]   [Full Text] [Related]  

  • 10. Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant Recipients.
    Li ZR; Li RD; Niu WJ; Zheng XY; Wang ZX; Zhong MK; Qiu XY
    J Clin Pharmacol; 2023 Mar; 63(3):314-325. PubMed ID: 36097320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of published population pharmacokinetic models to inform tacrolimus dosing in adult heart transplant recipients.
    Kirubakaran R; Hennig S; Maslen B; Day RO; Carland JE; Stocker SL
    Br J Clin Pharmacol; 2022 Feb; 88(4):1751-1772. PubMed ID: 34558092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?
    Brooks E; Tett SE; Isbel NM; Staatz CE
    Clin Pharmacokinet; 2016 Nov; 55(11):1295-1335. PubMed ID: 27138787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation.
    Monchaud C; de Winter BC; Knoop C; Estenne M; Reynaud-Gaubert M; Pison C; Stern M; Kessler R; Guillemain R; Marquet P; Rousseau A
    Clin Pharmacokinet; 2012 Mar; 51(3):175-86. PubMed ID: 22339449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients.
    Willis C; Staatz CE; Tett SE
    Ther Drug Monit; 2003 Apr; 25(2):158-66. PubMed ID: 12657909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.
    Benkali K; Rostaing L; Premaud A; Woillard JB; Saint-Marcoux F; Urien S; Kamar N; Marquet P; Rousseau A
    Clin Pharmacokinet; 2010 Oct; 49(10):683-92. PubMed ID: 20818834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External evaluation of published population pharmacokinetic models of polymyxin B.
    Li YQ; Chen KF; Ding JJ; Tan HY; Yang N; Lin YQ; Wu CF; Xie YL; Yang GP; Liu JJ; Pei Q
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1909-1917. PubMed ID: 34342716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.
    Lv C; Lu J; Jing L; Liu TT; Chen M; Zhang R; Li C; Zhou S; Wei Y; Chen Y
    J Clin Pharm Ther; 2021 Jun; 46(3):820-831. PubMed ID: 33751618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Published Population Pharmacokinetic Models to Inform Tacrolimus Therapy in Adult Lung Transplant Recipients.
    Kirubakaran R; Singh RM; Carland JE; Day RO; Stocker SL
    Ther Drug Monit; 2024 May; ():. PubMed ID: 38723160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.
    Mao JJ; Jiao Z; Yun HY; Zhao CY; Chen HC; Qiu XY; Zhong MK
    Br J Clin Pharmacol; 2018 Jan; 84(1):153-171. PubMed ID: 28891596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients.
    Kirubakaran R; Uster DW; Hennig S; Carland JE; Day RO; Wicha SG; Stocker SL
    Br J Clin Pharmacol; 2023 Mar; 89(3):1162-1175. PubMed ID: 36239542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.